Renalytix, the kidney disease diagnostics company, is offering up to 16.67m new shares to retail investors through the Winterflood Retail Access Platform (WRAP), seeking to raise up to £1m at 6p per share.
The offer runs alongside a £10.1m placing and subscription announced on 1 September, priced at the same 6p level, of which £0.9m depends on shareholder approval at a forthcoming general meeting.
That price represents a premium of approximately 44.6% to Renalytix's mid-market closing price of 4.15p on 28 August, and a 139% premium to its 90-day average closing price.
Proceeds from the retail offer will be used for the same purposes as the placing, though the two are not the same instrument.
Completion of the WRAP offer depends on the placing completing, but the placing itself does not depend on the retail offer's success.
Eligible UK investors, new or existing, can apply through participating brokers or wealth managers, subject to a £100 minimum subscription.
The WRAP offer closes at 4pm on 7 September, with results expected on or around 8 September.
News Intelligence what this means for the company
Renalytix is raising £11.1m gross (£1m retail offer plus £10.1m placing/subscription) at 6p per share, a 44.6% premium to the stock's closing price two days prior. This represents a modest increase on the £9.5m the company planned to raise through a placing, subscription and retail offer at the same 6p price, suggesting either stronger demand or a deliberate upsize. The retail tranche depends on the institutional placing completing, but not vice versa—a structure that protects the core fundraise.
The raise funds the same strategic purposes as the earlier September 1st announcement, likely supporting the Quest Diagnostics commercialisation pathway and 2027 ordering targets already disclosed. The pricing premium and retail component suggest investor appetite.
Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.
Content is for informational purposes only, not financial advice.
